AG-2/AGR2 Antibody [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # AF6068W
Conjugate
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Immunohistochemistry, Western Blot
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Polyclonal Sheep IgG
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
E. coli-derived recombinant human AG-2/AGR2
Arg21-Leu175
Accession # O95994
Arg21-Leu175
Accession # O95994
Specificity
Detects human AG-2/AGR2 in direct ELISA and Western blots. In direct ELISAs, approximately 20% cross‑reactivity with recombinant human AG-3 is observed.
Clonality
Polyclonal
Host
Sheep
Isotype
IgG
Applications for AG-2/AGR2 Antibody [DyLight 650]
Application
Recommended Usage
Immunohistochemistry
Optimal dilutions of this antibody should be experimentally determined.
Western Blot
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Antigen Affinity-purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: AG-2/AGR2
Long Name
Anterior Gradient 2 Homolog
Alternate Names
AG2, AGR2, GOB-4, HPC8, PDIA17
Gene Symbol
AGR2
Additional AG-2/AGR2 Products
Product Documents for AG-2/AGR2 Antibody [DyLight 650]
Product Specific Notices for AG-2/AGR2 Antibody [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...